Top View
- CCL17 Production of the Chemokines CCL1 and T Cell Activation Through
- Therapeutic Mir-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease
- Recruitment Via a CCL1 Dependent Pathway Statins Induce Regulatory
- CCR8+Foxp3+ Treg Cells As Master Drivers of Immune Regulation
- Expansion of CCR8 Inflammatory Myeloid Cells in Cancer Patients
- Products for Chemokine Research
- CXCL9, but Not CXCL10, Promotes CXCR3-Dependent Immune-Mediated Kidney Disease
- Plasma Chemokines Are Biomarkers of Disease Severity, Higher Bacterial Burden and Delayed Sputum Culture Conversion in Pulmonary Tuberculosis
- In Vivo NIR-II Structured-Illumination Light-Sheet Microscopy
- CCL18 in the Progression of Cancer
- Infiltration Into Antigen-Challenged Skin Perforin Directs Effector CD8 T
- Identification of CCL1 As a Gene Differentially Expressed in CD4+ T Cells Expressing TIM-3
- REALLY ESSENTIAL MEDICAL IMMUNOLOGY Arthur Rabson, Ivan M.Roitt, Peter J
- World Journal of Gastroenterology
- Upregulation of Chemokine CXCL10 Enhances Chronic Pulmonary
- CC Chemokines in a Tumor: a Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
- Circulating Chemokine Ligand Levels Before and After Successful Kidney Transplantation Hamdi Elmoselhi1, Holly Mansell2, Mahmoud Soliman1 and Ahmed Shoker1,3*
- Macrophage Derived CXCL9 and CXCL10 Are Required for Anti-Tumor Immune Responses Following Immune Checkpoint Blockade
- Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
- Comprehensive Assessment of Chemokine Expression Profiles by Flow Cytometry
- CC Chemokine Ligand 18 in ANCA-Associated Vasculitis
- Multiplexed Cancer Immune Response Analysis Ncounter® Pancancer Immune Profiling Panel for Gene Expression
- CC Chemokine Receptor 8 (CCR8) Immune Pathway Fact Sheet
- Comparison of the Chemokine Profiles in the Bronchoalveolar Lavage Fluid
- CCR8+Foxp3+ Treg Cells As Master Drivers of Immune Regulation
- Immunology; an Illustrated Outline; Sixth Edition
- Suppressing Neuroinflammation Using Nf-Κb Inhibitors
- Macrophages Transcriptome in Monocyte-Derived CXC Chemokine
- Erythrocyte Duffy Antigen Receptor for Chemokines (DARC): Diagnostic and Therapeutic Implications in Atherosclerotic Cardiovascular Disease
- Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation
- Chemokines and Immunity Quimiocinas E Imunidade
- Fluorokine Biotinylated Human I-309/CCL1
- CCL1, IL-22, and IL-36Β Have Higher Expression Levels in Aqueous Humor of Neovascular Age-Related Macular Degeneration Patients in Comparison to Cataract Patients
- Human CCL18/PARC Quantikine ELISA
- Interleukin-8, a Chemotactic and Inflammatory Cytokine
- Expression of Chemokines CXCL4 and CXCL7 by Synovial
- Allergyand Clinical Immunology
- Oncostatin M-Induced and Constitutive Activation of the JAK2/STAT5/CIS Pathway Suppresses CCL1, but Not CCL7 and CCL8, Chemokine Expression1
- Disruption of the CCL1-CCR8 Axis Inhibits Vascular Treg Recruitment and Function and Promotes Atherosclerosis in Mice
- Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells
- 655.Full.Pdf
- Impaired Microrna Processing in Neutrophils from Rheumatoid
- CC Chemokines in a Tumor: a Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
- The Combination of CXCL9, CXCL10 and CXCL11 Levels During Primary